A new study from researchers across the country found that women, particularly those in middle age, have a higher risk of developing long COVID than men, muddying the medical water further.

Weekly flu cases tripled in Washington state over the course of December, with hospitalizations on the rise as well, according to DOH data.

Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, sore throat, loss of taste or smell, fatigue and body aches, headache, nausea or vomiting or diarrhea, according to the CDC.

Jan. 20, 2025, marks five years since the CDC reported the first laboratory-confirmed case of COVID-19 on American soil.

WASHINGTON — In the winter ... Flu symptoms tend to hit more quickly than cold symptoms, and can last anywhere from a few days to two weeks. — COVID-19 can cause fever, chills, cough, short ...

OLYMPIA, Wash. - Today, January 20, 2025 will be the five year anniversary of the first reported case of COVID-19 in Washington State by the Centers for Disease Control (CDC).

Risk of long COVID is higher in women and a link between SARS-CoV-2 infection and development of ME/CFS is shown, according to new studies.

Jake Sullivan, the outgoing national security adviser, is asking a panel of outside experts to examine the government’s conclusions on how the pandemic began.

New biomarker tests can enable early diagnosis and prompt treatment of symptoms associated with synucleinopathies, according to a new expert-led clinical proceedings paper from the Clinical Neurological Society of America.

Flu symptoms tend to hit more quickly than cold symptoms, and can last anywhere from a few days to two weeks. — COVID-19 can cause fever ... The New York Times, The Washington Post or Bloomberg News. Rather, we focus on discussions related to local ...

When people hear that Kahidreuna Jones of Natchez graduated from high school at 14 and started college at 16, they tell her she must be a genius, she said. “But I’m just like anybody else,” Jones said.

The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market. Patients and scientists say it’s time to push harder for breakthroughs.